首页> 外文期刊>Genetic Testing >Glutathione S-Transferase M1 and T1 Genes and Susceptibility to Chronic Myeloid Leukemia: A Meta-Analysis
【24h】

Glutathione S-Transferase M1 and T1 Genes and Susceptibility to Chronic Myeloid Leukemia: A Meta-Analysis

机译:谷胱甘肽S-转移酶M1和T1基因和对慢性粒细胞白血病的易感性:荟萃分析。

获取原文
获取原文并翻译 | 示例
       

摘要

Variants of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genes have been implicated as risk factors for chronic myeloid leukemia (CML). However, the genetic association studies that examined the relation between the null genotypes of GSTM1 and GSTT1 genes and risk of developing CML gave conflicting or inconclusive results. In an attempt to interpret these results, a meta-analysis of all available studies (nine studies, with 757 cases and 1959 controls) was performed. In the meta-analysis the pooled odds ratios (OR) were estimated using random effects models. The heterogeneity between studies, the sources of potential bias, and the consistency of genetic effects across ethnicities were explored. Cumulative meta-analysis was also performed. Overall, the meta-analysis showed nonsignificant association between GSTM1 null genotype and CML (OR =1.00 [0.83-1.20]) and lack of heterogeneity between the studies (pq = 0.87). The association was also nonsignificant in Whites, East Asians, and Indians: OR = 1.38 (0.43-4.46), 0.94 (0.65-1.35), and 1.16 (0.74-1.82), respectively. However, GSTT1 null genotype was associated with increased risk of CML (OR =1.57 [1.13-2.17]) and the heterogeneity between studies was significant (pQ = 0.04). In Indians, the association was significant (OR = 2.89 [1.56-5.35]) whereas in East Asians it was not significant (OR = 1.07 [0.74-1.54]). The combined GSTM1 normal/ GSTT1 null genotypes produced significant association (OR =1.95 [1.17-3.24]). Cumulative meta-analysis for GSTT1 gene showed an upward trend in risk effect, whereas the trend was downward in GSTM1. There was a differential magnitude of effect in large versus small studies. In conclusion, the accumulated evidence indicated an association between GSTT1 null genotype and CML.
机译:谷胱甘肽S-转移酶M1(GSTM1)和T1(GSTT1)基因的变异体被认为是慢性粒细胞白血病(CML)的危险因素。但是,遗传关联研究检查了GSTM1和GSTT1基因的无效基因型与发生CML的风险之间的关系,得出了矛盾或不确定的结果。为了解释这些结果,对所有可用研究(9项研究,有757例病例和1959例对照)进行了荟萃分析。在荟萃分析中,使用随机效应模型估算合并的优势比(OR)。研究之间的异质性,潜在偏见的来源,以及跨种族遗传效应的一致性。还进行了累积荟萃分析。总体而言,荟萃分析显示GSTM1无效基因型与CML之间无显着相关性(OR = 1.00 [0.83-1.20]),并且研究之间缺乏异质性(pq = 0.87)。在白人,东亚人和印度人中,该关联也不显着:OR分别为1.38(0.43-4.46),0.94(0.65-1.35)和1.16(0.74-1.82)。然而,GSTT1无效基因型与CML风险增加相关(OR = 1.57 [1.13-2.17]),研究之间的异质性很明显(pQ = 0.04)。在印度人中,这种关联是显着的(OR = 2.89 [1.56-5.35]),而在东亚地区,则没有显着性(OR = 1.07 [0.74-1.54])。结合的GSTM1正常/ GSTT1无效基因型产生显着关联(OR = 1.95 [1.17-3.24])。 GSTT1基因的累积荟萃分析显示风险效应呈上升趋势,而GSTM1呈下降趋势。大型研究与小型研究的效果差异很大。总之,积累的证据表明GSTT1无效基因型与CML之间存在关联。

著录项

  • 来源
    《Genetic Testing》 |2009年第6期|791-797|共7页
  • 作者

    Elias Zintzaras;

  • 作者单位

    Department of Biomathematics University of Thessaly School of Medicine Papakyriazi 22 41222 Larissa Greece Center for Clinical Evidence Synthesis, The Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:21:33

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号